Palantir's UK Chief Defends NHS Contract as Ministers Consider Break Clause
Louis Mosley, the executive vice-chair of Palantir in the UK, has publicly criticised what he terms "ideologically motivated campaigners" as government ministers actively explore options to terminate a £330 million contract with the US data analytics company for the NHS Federated Data Platform (FDP). This move comes amid escalating scrutiny over Palantir's extensive involvement across various UK public sectors, including the Ministry of Defence, multiple police forces, and the Financial Conduct Authority.
Contractual Review and Political Pressure
Ministers have reportedly sought legal advice on activating a break clause in Palantir's agreement to deliver the FDP, an AI-enabled system designed to integrate disparate health information across the National Health Service. According to reports from the Financial Times, government officials believe it is feasible to transfer the platform's management to another provider once the contract becomes active next year. However, Mosley argues that such action would be detrimental, stating, "Having a review clause in a contract is good and normal practice. However, what some ideologically motivated campaigners are suggesting should happen would harm patient care and prevent some of the biggest challenges facing the NHS from being tackled."
He emphasised that Palantir's software has demonstrated tangible benefits over the past two years, with forecasts predicting £150 million in savings by the end of the decade, equating to a £5 return for every pound invested. Despite these claims, health officials have expressed concerns that Palantir's controversial reputation could jeopardise the successful delivery of the FDP contract. The British Medical Association (BMA) has consistently opposed Palantir's involvement in NHS data systems, citing ethical apprehensions.
Reputational Risks and Political Spectrum
Palantir, named after the all-seeing orbs in J.R.R. Tolkien's The Lord of the Rings, is a US-based firm that also provides services to the Israeli and US militaries, as well as Donald Trump's Immigration and Customs Enforcement (ICE) operation. This has sparked protests from groups such as pro-Palestine NHS workers, who argue against awarding contracts to a company with such affiliations. Health Secretary Wes Streeting acknowledged these worries in a recent interview, noting that Palantir's leadership, including founder Peter Thiel, holds political views that would place them "well off to the right of even Kemi Badenoch's Conservative party" in the UK context.
Nevertheless, Streeting clarified that Palantir does not have access to patient data processed through its systems, asserting, "The platform they have given to us to improve our systems our performances, intelligence and tackling health inequalities, all of that is run by us, Palantir don't see our patient data." He added that being in government allows for greater oversight to ensure data security and confidentiality, which are strict requirements under the FDP framework.
Growing Public Awareness and Strategic Concerns
The issue of Palantir's role in UK infrastructure is gaining traction beyond traditional critics like the Labour left and Green Party. Clive Lewis, Labour MP for Norwich South, observed that voters are increasingly mentioning Palantir on the doorstep, linking it to broader anxieties about artificial intelligence and technological change. He suggested, "It's obvious in the case of defence, but that also percolates down to healthcare data. What was unthinkable 18 months to a year ago in terms of our relationship with the US and US companies is now very much on people's minds."
Currently, 151 NHS organisations utilise Palantir technology, up from 118 in June, though this falls short of the target of 240 by year-end. A Department of Health and Social Care spokesperson reiterated that the FDP aims to enhance patient care, boost productivity, accelerate cancer diagnoses, and treat thousands more patients monthly, with each hospital trust maintaining control over data access. As debates intensify, the government faces mounting pressure to balance technological advancement with ethical considerations and public trust in sensitive sectors like healthcare and defence.
